annual cash & cash equivalents:
$543.06M-$153.08M(-21.99%)Summary
- As of today (September 9, 2025), RVMD annual cash & cash equivalents is $543.06 million, with the most recent change of -$153.08 million (-21.99%) on December 31, 2024.
- During the last 3 years, RVMD annual cash & cash equivalents has risen by +$434.57 million (+400.53%).
- RVMD annual cash & cash equivalents is now -21.99% below its all-time high of $696.15 million, reached on December 31, 2023.
Performance
RVMD Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$2.14B+$34.50M(+1.64%)Summary
- As of today (September 9, 2025), RVMD quarterly cash & cash equivalents is $2.14 billion, with the most recent change of +$34.50 million (+1.64%) on June 30, 2025.
- Over the past year, RVMD quarterly cash & cash equivalents has increased by +$546.46 million (+34.35%).
- RVMD quarterly cash & cash equivalents is now -6.65% below its all-time high of $2.29 billion, reached on December 31, 2024.
Performance
RVMD quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RVMD Cash and cash equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -22.0% | +34.4% |
3 y3 years | +400.5% | +363.2% |
5 y5 years | +3159.9% | +556.7% |
RVMD Cash and cash equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -22.0% | +400.5% | -6.7% | +363.2% |
5 y | 5-year | -22.0% | +3159.9% | -6.7% | +556.7% |
alltime | all time | -22.0% | +5881.5% | -6.7% | +2971.3% |
RVMD Cash and cash equivalents History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $2.14B(+1.6%) |
Mar 2025 | - | $2.10B(-8.2%) |
Dec 2024 | $543.06M(-22.0%) | $2.29B(+47.7%) |
Sep 2024 | - | $1.55B(-2.6%) |
Jun 2024 | - | $1.59B(-6.6%) |
Mar 2024 | - | $1.70B(-8.1%) |
Dec 2023 | $696.15M(+331.3%) | $1.85B(+127.9%) |
Sep 2023 | - | $813.20M(-10.6%) |
Jun 2023 | - | $909.49M(-0.0%) |
Mar 2023 | - | $909.80M(+41.1%) |
Dec 2022 | $161.41M | $644.94M(-1.5%) |
Sep 2022 | - | $655.01M(+42.0%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $461.43M(-11.0%) |
Mar 2022 | - | $518.75M(-10.1%) |
Dec 2021 | $108.50M(+4.1%) | $577.05M(-5.2%) |
Sep 2021 | - | $608.65M(-5.8%) |
Jun 2021 | - | $646.32M(-5.2%) |
Mar 2021 | - | $681.59M(+54.6%) |
Dec 2020 | $104.27M(+525.9%) | $440.74M(-5.4%) |
Sep 2020 | - | $466.14M(+43.2%) |
Jun 2020 | - | $325.44M(-6.5%) |
Mar 2020 | - | $347.95M(+183.4%) |
Dec 2019 | $16.66M(-76.1%) | $122.76M(+76.4%) |
Dec 2018 | $69.59M(+666.5%) | $69.59M |
Dec 2017 | $9.08M | - |
FAQ
- What is Revolution Medicines, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Revolution Medicines, Inc.?
- What is Revolution Medicines, Inc. annual cash & cash equivalents year-on-year change?
- What is Revolution Medicines, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Revolution Medicines, Inc.?
- What is Revolution Medicines, Inc. quarterly cash & cash equivalents year-on-year change?
What is Revolution Medicines, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of RVMD is $543.06M
What is the all time high annual cash & cash equivalents for Revolution Medicines, Inc.?
Revolution Medicines, Inc. all-time high annual cash & cash equivalents is $696.15M
What is Revolution Medicines, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, RVMD annual cash & cash equivalents has changed by -$153.08M (-21.99%)
What is Revolution Medicines, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of RVMD is $2.14B
What is the all time high quarterly cash & cash equivalents for Revolution Medicines, Inc.?
Revolution Medicines, Inc. all-time high quarterly cash & cash equivalents is $2.29B
What is Revolution Medicines, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, RVMD quarterly cash & cash equivalents has changed by +$546.46M (+34.35%)